Menu
GeneBe

5-90642617-G-T

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_032119.4(ADGRV1):​c.2241-19G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.165 in 1,604,350 control chromosomes in the GnomAD database, including 24,003 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.18 ( 2691 hom., cov: 32)
Exomes 𝑓: 0.16 ( 21312 hom. )

Consequence

ADGRV1
NM_032119.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 0.615
Variant links:
Genes affected
ADGRV1 (HGNC:17416): (adhesion G protein-coupled receptor V1) This gene encodes a member of the G-protein coupled receptor superfamily. The encoded protein contains a 7-transmembrane receptor domain, binds calcium and is expressed in the central nervous system. Mutations in this gene are associated with Usher syndrome 2 and familial febrile seizures. Several alternatively spliced transcripts have been described. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 5-90642617-G-T is Benign according to our data. Variant chr5-90642617-G-T is described in ClinVar as [Benign]. Clinvar id is 137502.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-90642617-G-T is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.389 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
ADGRV1NM_032119.4 linkuse as main transcriptc.2241-19G>T intron_variant ENST00000405460.9

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
ADGRV1ENST00000405460.9 linkuse as main transcriptc.2241-19G>T intron_variant 1 NM_032119.4 P1Q8WXG9-1
ADGRV1ENST00000640403.1 linkuse as main transcriptc.-457-19G>T intron_variant 5
ADGRV1ENST00000504142.2 linkuse as main transcriptn.1007-19G>T intron_variant, non_coding_transcript_variant 5

Frequencies

GnomAD3 genomes
AF:
0.181
AC:
27498
AN:
151870
Hom.:
2679
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.201
Gnomad AMI
AF:
0.120
Gnomad AMR
AF:
0.150
Gnomad ASJ
AF:
0.221
Gnomad EAS
AF:
0.402
Gnomad SAS
AF:
0.231
Gnomad FIN
AF:
0.183
Gnomad MID
AF:
0.171
Gnomad NFE
AF:
0.154
Gnomad OTH
AF:
0.175
GnomAD3 exomes
AF:
0.188
AC:
45269
AN:
240940
Hom.:
4885
AF XY:
0.188
AC XY:
24485
AN XY:
130442
show subpopulations
Gnomad AFR exome
AF:
0.201
Gnomad AMR exome
AF:
0.141
Gnomad ASJ exome
AF:
0.222
Gnomad EAS exome
AF:
0.404
Gnomad SAS exome
AF:
0.225
Gnomad FIN exome
AF:
0.191
Gnomad NFE exome
AF:
0.153
Gnomad OTH exome
AF:
0.175
GnomAD4 exome
AF:
0.164
AC:
237845
AN:
1452362
Hom.:
21312
Cov.:
31
AF XY:
0.166
AC XY:
119757
AN XY:
721968
show subpopulations
Gnomad4 AFR exome
AF:
0.204
Gnomad4 AMR exome
AF:
0.142
Gnomad4 ASJ exome
AF:
0.218
Gnomad4 EAS exome
AF:
0.385
Gnomad4 SAS exome
AF:
0.225
Gnomad4 FIN exome
AF:
0.184
Gnomad4 NFE exome
AF:
0.148
Gnomad4 OTH exome
AF:
0.181
GnomAD4 genome
AF:
0.181
AC:
27539
AN:
151988
Hom.:
2691
Cov.:
32
AF XY:
0.185
AC XY:
13751
AN XY:
74296
show subpopulations
Gnomad4 AFR
AF:
0.201
Gnomad4 AMR
AF:
0.150
Gnomad4 ASJ
AF:
0.221
Gnomad4 EAS
AF:
0.403
Gnomad4 SAS
AF:
0.230
Gnomad4 FIN
AF:
0.183
Gnomad4 NFE
AF:
0.154
Gnomad4 OTH
AF:
0.182
Alfa
AF:
0.157
Hom.:
2703
Bravo
AF:
0.179
Asia WGS
AF:
0.316
AC:
1097
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, criteria provided, single submitterclinical testingGeneDxJan 08, 2013This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Benign, no assertion criteria providedclinical testingJoint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+-- -
Benign, no assertion criteria providedclinical testingDiagnostic Laboratory, Department of Genetics, University Medical Center Groningen-- -
Usher syndrome type 2C Benign:1
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabAug 10, 2021- -
not provided Benign:1
Benign, criteria provided, single submitterclinical testingInvitaeFeb 01, 2024- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
3.6
DANN
Benign
0.50

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1344030; hg19: chr5-89938434; COSMIC: COSV67978715; COSMIC: COSV67978715; API